Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uppsala Monitoring Centre (UMC) is an independent, non-profit foundation and a world leader in pharmacovigilance and patient safety. As the WHO Collaborating Centre for International Drug Monitoring, UMC manages VigiBase, the global database of individual case safety reports (ICSRs), which contains millions of records from over 150 countries. The organization provides essential tools and services to national regulatory authorities and pharmaceutical companies, including the WHO Drug Global dictionary and VigiLyze signal detection software. UMC's work focuses on identifying drug safety signals, developing international standards for medicinal product information, and promoting the safe use of medicines worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uppsala.